Burjeel Holdings and Hippocratic AI Announce Strategic Partnership to Advance Safe and Empathetic Generative AI Healthcare Agents

April 17, 2025 at 09:15 AM EDT

Collaboration to deploy empathetic generative AI agents across Burjeel Holdings’ network to enhance patient care, address staffing shortages, and drive healthcare transformation across the UAE and Oman.

Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region and Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, today announced a strategic partnership aimed at transforming healthcare delivery through safe, scalable, and empathetic AI. The initiative was kicked off during the Abu Dhabi Global Healthcare Week.

The collaboration will see Hippocratic AI’s generative AI healthcare agents, built for patient-facing non-diagnostic clinical tasks, deployed across Burjeel Holdings’ hospitals, medical centers, and physiotherapy clinics in the UAE and Oman. By integrating Hippocratic AI’s cutting-edge AI capabilities, Burjeel Holdings aims to transform the patient engagement experience, providing personalized and compassionate clinical conversations that address patient needs. Their introduction aligns with the Group’s commitment to integrating advanced technology in healthcare while maintaining a human-centric approach.

Mr. John Sunil, Group Chief Executive Officer of Burjeel Holdings, said, "At Burjeel Holdings, we believe that the future of healthcare lies in the perfect harmony between cutting-edge technology and personalized care. Our partnership with Hippocratic AI is a testament to our ongoing mission to leverage AI to improve patient experience, efficiency, reduce wait times, and ultimately provide better health outcomes for our patients."

What sets these agents apart is their ability to engage in natural, safety-focused, human-like conversations. Through the integration of Hippocratic AI’s multilingual, empathy-driven agents, Burjeel Holdings will deliver real-time, culturally aware support across a wide range of patient touchpoints, including appointment scheduling, patient education, health risk assessments, and follow-up check ins. These advanced agents are capable of sustained, multi-turn dialogue, enabling them to provide consistent, compliant, and compassionate communication that enhances both the patient experience and care continuity.

Mr. Munjal Shah, Co-Founder and CEO of Hippocratic AI, said, “We’re proud to partner with Burjeel Holdings, one of the most respected healthcare systems in the region. This partnership supports our shared mission of achieving healthcare abundance. Our empathic genAI agents are designed to create a more compassionate and effective patient experience. Together, we will tailor our solutions to meet the specific needs of the communities we serve.”

Hippocratic AI recently unveiled its patented Polaris 3.0, its most advanced and safety-focused constellation architecture to date. Built on extensive real-world insights from both patients and healthcare providers. With over 1.85 million patient calls and collaborations with more than 25 healthcare enterprise partners, it has set a new benchmark in patient safety and satisfaction, achieving a clinical accuracy rate of 99.38% and a record-high patient experience rating of 8.95 out of 10. At the core of the Polaris constellation system are specialized supervisor models that oversee critical areas such as medications, labs and vitals, nutrition, escalation protocols, and hospital-specific policies.

Key highlights of the partnership include the deployment of multilingual AI agents, including Arabic and the Emirati dialect, ensuring effective communication with the region’s diverse patient population. Hippocratic AI’s agents already speak over 15 widely used languages such as Spanish, Mandarin, and Vietnamese, as well as more localized dialects like Emirati Arabic, with plans to expand linguistic coverage to nearly all major global languages. The collaboration will also deliver customized regional generative AI agents tailored for cultural alignment and local relevance, enhancing the quality and empathy of patient interactions. In addition, AI agents will be deployed across key specialties such as oncology, cardiology, neurology, and orthopedics, supporting both clinical and administrative tasks to help streamline operations and elevate the patient experience.

The partnership focuses on expanding the deployment of these genAI healthcare agents across Burjeel Holdings' facilities, ensuring that healthcare providers can access the latest advancements in technology and patient support. Incorporating AI technologies into the complex care environment aligns with Burjeel Holdings' commitment to transforming healthcare delivery across critical areas.

This collaboration reflects a shared vision: harnessing safety-focused generative AI to support healthcare systems, ease staffing challenges, and deliver hyper-personalized, compassionate care, advancing the collective goal of healthcare abundance.

About Hippocratic AI

Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA’s NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, visit www.HippocraticAI.com.

About Burjeel Holdings

Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia. The Group operates an integrated and multi-brand healthcare ecosystem across primary, secondary, tertiary, and quaternary medical care, ensuring complex care delivery to patients across all socioeconomic groups. Its network comprises 100 assets across the UAE, Oman, and Saudi Arabia, including 19 hospitals, 29 medical centers, 29 physiotherapy and wellness centers, 15 pharmacies, and other allied services. Burjeel Holdings’ brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia and Tajmeel.